525 related articles for article (PubMed ID: 32493915)
21. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
Tian S; Liu J; Kong S; Peng L
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
Yang G; Song R; Wang L; Wu X
Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
[TBL] [Abstract][Full Text] [Related]
23. Association of a novel antisense lncRNA TP73-AS1 polymorphisms and expression with colorectal cancer susceptibility and prognosis.
Fan J; Xu H; Liu B; Jing F; He Q; Zheng S; Shi H; Jiao L; Fan C
Genes Genomics; 2022 Jul; 44(7):889-897. PubMed ID: 34480734
[TBL] [Abstract][Full Text] [Related]
24. The clinical prognostic value of long noncoding RNA HAND2-AS1 in cancer patients: A study based on meta-analysis and TCGA data (PRISMA).
Yan Z; Lu J; Xu X; You Y; Xu J; Xu T
Medicine (Baltimore); 2022 Sep; 101(39):e30789. PubMed ID: 36181101
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and Prognostic Role of Long Noncoding RNA Linc00152 in Various Human Neoplasms: Evidence from Meta-Analysis.
Miao C; Zhao K; Zhu J; Liang C; Xu A; Hua Y; Zhang J; Liu S; Tian Y; Zhang C; Wang Y; Su S; Wang Z; Liu B
Biomed Res Int; 2017; 2017():6010721. PubMed ID: 29285514
[TBL] [Abstract][Full Text] [Related]
26. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.
Chen C; Feng Y; Wang X
Clin Chim Acta; 2018 Sep; 484():265-271. PubMed ID: 29885321
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA LINC00152 as a novel predictor of lymph node metastasis and survival in human cancer: a systematic review and meta-analysis.
Zhang J; Yin M; Huang J; Lv Z; Liang S; Miao X; Huang F; Zhao Y
Clin Chim Acta; 2018 Aug; 483():25-32. PubMed ID: 29617624
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of long noncoding RNA TTN-AS1 in various malignancies.
Lin G; Liu X; Cong C; Xu L
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1876. PubMed ID: 37528740
[TBL] [Abstract][Full Text] [Related]
29. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China.
Liu RH; Wang MY; Chen LY; Yin ZJ; Ji QK; Wang YY; Jin BZ
Oncotarget; 2018 Jan; 9(8):8100-8110. PubMed ID: 29487718
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-223-5p targets long non-coding RNA TP73 antisense RNA1 to promote the invasion of gastric cancer.
Liu J; Wang H; Liao X
Hum Cell; 2020 Jul; 33(3):676-682. PubMed ID: 32248369
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA TP73-AS1 in human cancers.
Chu F; Xue L; Miao H
Clin Chim Acta; 2020 Jan; 500():104-108. PubMed ID: 31678571
[TBL] [Abstract][Full Text] [Related]
33. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
Wang X; Yang B; She Y; Ye Y
J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
[TBL] [Abstract][Full Text] [Related]
34. The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis.
Fu L; Zhang G; Wang Y; Lu T; Liu B; Jiao Y; Ma H; Ma S; Yang K; Cai H
Dis Markers; 2022; 2022():4466776. PubMed ID: 35783010
[TBL] [Abstract][Full Text] [Related]
35. LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis.
Wang X; Chen Z; Zhou H; Liu W; Luo J
Medicine (Baltimore); 2022 Dec; 101(52):e32436. PubMed ID: 36596047
[TBL] [Abstract][Full Text] [Related]
36. The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.
Zuo XL; Cai J; Chen ZQ; Zhang Y; Liang LH; Wang JF; Wang JG; Wu J; Mao JD
Clin Chim Acta; 2018 Oct; 485():14-20. PubMed ID: 29906419
[TBL] [Abstract][Full Text] [Related]
37. Enhanced expression of lncRNA TP73-AS1 predicts unfavorable prognosis for gastric cancer and promotes cell migration and invasion by induction of EMT.
Zhang W; Zhai Y; Wang W; Cao M; Ma C
Gene; 2018 Dec; 678():377-383. PubMed ID: 30118890
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
39. LncRNA TP73-AS1 predicts poor prognosis and functions as oncogenic lncRNA in osteosarcoma.
Chen X; Zhou Y; Liu S; Zhang D; Yang X; Zhou Q; Song Y; Liu Y
J Cell Biochem; 2019 Feb; 120(2):2569-2575. PubMed ID: 30216569
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
